Medicamentos retirados en otros países por problemas de seguridad: ¿Deben seguir presentes en el mercado farmacéutico argentino?

Autores
Buschaizzo, Héctor O.; Dorati, Cristian M.; Venturini, Nasim Iusef; Cañás, Martín; Urtasun, Martín Alejandro; Marin, Gustavo Horacio; Prozzi, Guillermo Rafael; Rivadulla, Patricia Alejandra; Trionfetti, Mariángeles; Mordujovich de Buschiazzo, Perla
Año de publicación
2022
Idioma
español castellano
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Introduction: Numerous medicines have been withdrawn from the market because of therisks of serious adverse effects. The objective of this study was to identify in the Argentinepharmaceutical market (APM) the presence of medicines withdrawn in other countries dueto safety problems, to analyze the information on their risks and to proposerecommendations. Method: observational, descriptive study that explored the presence inthe APM, until May 2021, of 462 medicines withdrawn in other countries. Those medicineson this list that are present in the APM and that are not currently authorized in countrieswith high sanitary surveillance were studied. Results: 17 medicines are still present in theAPM, one over-the-counter. The package insert for 11 of the 17 medicines does notmention the adverse effects that led to their withdrawal. It was considered that thepermanence in the APM of 16 of them should be reassessed. Conclusions:recommendations are made on actions to be taken by the regulatory authorities with the17 medicines already present in the APM.
Fil: Buschaizzo, Héctor O.. Universidad Nacional de La Plata; Argentina
Fil: Dorati, Cristian M.. Universidad Nacional de La Plata; Argentina
Fil: Venturini, Nasim Iusef. Universidad Nacional de La Plata; Argentina
Fil: Cañás, Martín. Universidad Nacional Arturo Jauretche; Argentina
Fil: Urtasun, Martín Alejandro. Universidad Nacional Arturo Jauretche; Argentina. Universidad Nacional de La Plata; Argentina
Fil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina
Fil: Prozzi, Guillermo Rafael. Universidad Nacional de La Plata; Argentina
Fil: Rivadulla, Patricia Alejandra. Universidad Nacional de La Plata; Argentina
Fil: Trionfetti, Mariángeles. Universidad Nacional de La Plata; Argentina
Fil: Mordujovich de Buschiazzo, Perla. Universidad Nacional de La Plata; Argentina
Materia
MEDICAMENTOS
SEGURIDAD
MERCADO
RETIRO
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/218209
Acceder
id CONICETDig_7aff9076ed044342c47eecc109e6f176
oai_identifier_str oai:ri.conicet.gov.ar:11336/218209
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Medicamentos retirados en otros países por problemas de seguridad: ¿Deben seguir presentes en el mercado farmacéutico argentino?Medicines withdrawn in other countries due to safety concerns: Should they continue to be available in the Argentine pharmaceutical market?Remédios retirados em outros países devido a problemas de segurança: Devem continuar presentes no mercado farmacêutico argentino?Buschaizzo, Héctor O.Dorati, Cristian M.Venturini, Nasim IusefCañás, MartínUrtasun, Martín AlejandroMarin, Gustavo HoracioProzzi, Guillermo RafaelRivadulla, Patricia AlejandraTrionfetti, MariángelesMordujovich de Buschiazzo, PerlaMEDICAMENTOSSEGURIDADMERCADORETIROhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Introduction: Numerous medicines have been withdrawn from the market because of therisks of serious adverse effects. The objective of this study was to identify in the Argentinepharmaceutical market (APM) the presence of medicines withdrawn in other countries dueto safety problems, to analyze the information on their risks and to proposerecommendations. Method: observational, descriptive study that explored the presence inthe APM, until May 2021, of 462 medicines withdrawn in other countries. Those medicineson this list that are present in the APM and that are not currently authorized in countrieswith high sanitary surveillance were studied. Results: 17 medicines are still present in theAPM, one over-the-counter. The package insert for 11 of the 17 medicines does notmention the adverse effects that led to their withdrawal. It was considered that thepermanence in the APM of 16 of them should be reassessed. Conclusions:recommendations are made on actions to be taken by the regulatory authorities with the17 medicines already present in the APM.Fil: Buschaizzo, Héctor O.. Universidad Nacional de La Plata; ArgentinaFil: Dorati, Cristian M.. Universidad Nacional de La Plata; ArgentinaFil: Venturini, Nasim Iusef. Universidad Nacional de La Plata; ArgentinaFil: Cañás, Martín. Universidad Nacional Arturo Jauretche; ArgentinaFil: Urtasun, Martín Alejandro. Universidad Nacional Arturo Jauretche; Argentina. Universidad Nacional de La Plata; ArgentinaFil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; ArgentinaFil: Prozzi, Guillermo Rafael. Universidad Nacional de La Plata; ArgentinaFil: Rivadulla, Patricia Alejandra. Universidad Nacional de La Plata; ArgentinaFil: Trionfetti, Mariángeles. Universidad Nacional de La Plata; ArgentinaFil: Mordujovich de Buschiazzo, Perla. Universidad Nacional de La Plata; ArgentinaUniversidad Nacional de Córdoba2022-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/218209Buschaizzo, Héctor O.; Dorati, Cristian M.; Venturini, Nasim Iusef; Cañás, Martín; Urtasun, Martín Alejandro; et al.; Medicamentos retirados en otros países por problemas de seguridad: ¿Deben seguir presentes en el mercado farmacéutico argentino?; Universidad Nacional de Córdoba; Revista de la Facultad de Ciencias Médicas de Córdoba; 79; 3; 9-2022; 241-2470014-67221853-0605CONICET DigitalCONICETspainfo:eu-repo/semantics/altIdentifier/doi/10.31053/1853.0605.v79.n3.35443info:eu-repo/semantics/altIdentifier/url/https://revistas.unc.edu.ar/index.php/med/article/view/35443info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:47:28Zoai:ri.conicet.gov.ar:11336/218209instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:47:28.469CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Medicamentos retirados en otros países por problemas de seguridad: ¿Deben seguir presentes en el mercado farmacéutico argentino?
Medicines withdrawn in other countries due to safety concerns: Should they continue to be available in the Argentine pharmaceutical market?
Remédios retirados em outros países devido a problemas de segurança: Devem continuar presentes no mercado farmacêutico argentino?
title Medicamentos retirados en otros países por problemas de seguridad: ¿Deben seguir presentes en el mercado farmacéutico argentino?
spellingShingle Medicamentos retirados en otros países por problemas de seguridad: ¿Deben seguir presentes en el mercado farmacéutico argentino?
Buschaizzo, Héctor O.
MEDICAMENTOS
SEGURIDAD
MERCADO
RETIRO
title_short Medicamentos retirados en otros países por problemas de seguridad: ¿Deben seguir presentes en el mercado farmacéutico argentino?
title_full Medicamentos retirados en otros países por problemas de seguridad: ¿Deben seguir presentes en el mercado farmacéutico argentino?
title_fullStr Medicamentos retirados en otros países por problemas de seguridad: ¿Deben seguir presentes en el mercado farmacéutico argentino?
title_full_unstemmed Medicamentos retirados en otros países por problemas de seguridad: ¿Deben seguir presentes en el mercado farmacéutico argentino?
title_sort Medicamentos retirados en otros países por problemas de seguridad: ¿Deben seguir presentes en el mercado farmacéutico argentino?
dc.creator.none.fl_str_mv Buschaizzo, Héctor O.
Dorati, Cristian M.
Venturini, Nasim Iusef
Cañás, Martín
Urtasun, Martín Alejandro
Marin, Gustavo Horacio
Prozzi, Guillermo Rafael
Rivadulla, Patricia Alejandra
Trionfetti, Mariángeles
Mordujovich de Buschiazzo, Perla
author Buschaizzo, Héctor O.
author_facet Buschaizzo, Héctor O.
Dorati, Cristian M.
Venturini, Nasim Iusef
Cañás, Martín
Urtasun, Martín Alejandro
Marin, Gustavo Horacio
Prozzi, Guillermo Rafael
Rivadulla, Patricia Alejandra
Trionfetti, Mariángeles
Mordujovich de Buschiazzo, Perla
author_role author
author2 Dorati, Cristian M.
Venturini, Nasim Iusef
Cañás, Martín
Urtasun, Martín Alejandro
Marin, Gustavo Horacio
Prozzi, Guillermo Rafael
Rivadulla, Patricia Alejandra
Trionfetti, Mariángeles
Mordujovich de Buschiazzo, Perla
author2_role author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv MEDICAMENTOS
SEGURIDAD
MERCADO
RETIRO
topic MEDICAMENTOS
SEGURIDAD
MERCADO
RETIRO
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Introduction: Numerous medicines have been withdrawn from the market because of therisks of serious adverse effects. The objective of this study was to identify in the Argentinepharmaceutical market (APM) the presence of medicines withdrawn in other countries dueto safety problems, to analyze the information on their risks and to proposerecommendations. Method: observational, descriptive study that explored the presence inthe APM, until May 2021, of 462 medicines withdrawn in other countries. Those medicineson this list that are present in the APM and that are not currently authorized in countrieswith high sanitary surveillance were studied. Results: 17 medicines are still present in theAPM, one over-the-counter. The package insert for 11 of the 17 medicines does notmention the adverse effects that led to their withdrawal. It was considered that thepermanence in the APM of 16 of them should be reassessed. Conclusions:recommendations are made on actions to be taken by the regulatory authorities with the17 medicines already present in the APM.
Fil: Buschaizzo, Héctor O.. Universidad Nacional de La Plata; Argentina
Fil: Dorati, Cristian M.. Universidad Nacional de La Plata; Argentina
Fil: Venturini, Nasim Iusef. Universidad Nacional de La Plata; Argentina
Fil: Cañás, Martín. Universidad Nacional Arturo Jauretche; Argentina
Fil: Urtasun, Martín Alejandro. Universidad Nacional Arturo Jauretche; Argentina. Universidad Nacional de La Plata; Argentina
Fil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina
Fil: Prozzi, Guillermo Rafael. Universidad Nacional de La Plata; Argentina
Fil: Rivadulla, Patricia Alejandra. Universidad Nacional de La Plata; Argentina
Fil: Trionfetti, Mariángeles. Universidad Nacional de La Plata; Argentina
Fil: Mordujovich de Buschiazzo, Perla. Universidad Nacional de La Plata; Argentina
description Introduction: Numerous medicines have been withdrawn from the market because of therisks of serious adverse effects. The objective of this study was to identify in the Argentinepharmaceutical market (APM) the presence of medicines withdrawn in other countries dueto safety problems, to analyze the information on their risks and to proposerecommendations. Method: observational, descriptive study that explored the presence inthe APM, until May 2021, of 462 medicines withdrawn in other countries. Those medicineson this list that are present in the APM and that are not currently authorized in countrieswith high sanitary surveillance were studied. Results: 17 medicines are still present in theAPM, one over-the-counter. The package insert for 11 of the 17 medicines does notmention the adverse effects that led to their withdrawal. It was considered that thepermanence in the APM of 16 of them should be reassessed. Conclusions:recommendations are made on actions to be taken by the regulatory authorities with the17 medicines already present in the APM.
publishDate 2022
dc.date.none.fl_str_mv 2022-09
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/218209
Buschaizzo, Héctor O.; Dorati, Cristian M.; Venturini, Nasim Iusef; Cañás, Martín; Urtasun, Martín Alejandro; et al.; Medicamentos retirados en otros países por problemas de seguridad: ¿Deben seguir presentes en el mercado farmacéutico argentino?; Universidad Nacional de Córdoba; Revista de la Facultad de Ciencias Médicas de Córdoba; 79; 3; 9-2022; 241-247
0014-6722
1853-0605
CONICET Digital
CONICET
url http://hdl.handle.net/11336/218209
identifier_str_mv Buschaizzo, Héctor O.; Dorati, Cristian M.; Venturini, Nasim Iusef; Cañás, Martín; Urtasun, Martín Alejandro; et al.; Medicamentos retirados en otros países por problemas de seguridad: ¿Deben seguir presentes en el mercado farmacéutico argentino?; Universidad Nacional de Córdoba; Revista de la Facultad de Ciencias Médicas de Córdoba; 79; 3; 9-2022; 241-247
0014-6722
1853-0605
CONICET Digital
CONICET
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.31053/1853.0605.v79.n3.35443
info:eu-repo/semantics/altIdentifier/url/https://revistas.unc.edu.ar/index.php/med/article/view/35443
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Universidad Nacional de Córdoba
publisher.none.fl_str_mv Universidad Nacional de Córdoba
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842268861091545088
score 13.13397

Publicaciones similares